Vaccine development and immunization are fundamental in preventing infectious diseases and promoting public health. Advances in immunology and biotechnology have accelerated the creation of vaccines for a wide range of diseases, significantly reducing morbidity and mortality worldwide. The ongoing development of vaccines, especially for emerging diseases, presents a critical tool in global disease control. However, challenges remain in ensuring equitable distribution, addressing vaccine hesitancy, and overcoming logistical barriers. Continuous research is essential for improving the efficacy and accessibility of vaccines, as well as for developing new vaccine technologies such as mRNA platforms. Collaborative efforts between governments, researchers, and healthcare professionals are key to maximizing the impact of vaccination programs and achieving herd immunity.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Gendered socioeconomic impacts of emerging infectious diseases: Insights from a mixed-methods study in Guinea
Stephanie Maltais, University of Montreal, Canada
Title : The role of social sciences in operationalizing the One Health approach: A case study of the DOPERAUS project in Guinea and the Democratic Republic of Congo
Stephanie Maltais, University of Montreal, Canada